Table 1 Patient and tumour characteristics in 33 patients treated with cetuximab based chemoradiotherapy
Patients (n) | % | |
|---|---|---|
Patients included | 33 | 100 |
Median age (range) | 61 (33 - 76) | |
Gender | ||
Male | 23 | 70 |
Female | 10 | 30 |
Performance Status (ECOG*) | ||
0 | 23 | 70 |
1 | 9 | 27 |
2 | 1 | 3 |
Tumour marker | ||
CEA, median (range) | 2,4 μg/l (0.5 - 50,3) | |
CA 19-9, median (range) | 10 kU/l (1 - 298) | |
Clinical T-staging (TRUS §§ ) | ||
cT2 | 6 | 18 |
cT3 | 24 | 73 |
cT4 | 3 | 9 |
Clinical N-staging (TRUS §§ ) | ||
cN negative | 10 | 30,3 |
cN positive | 23 | 69,7 |
TRG § (JSCCR ┼┼ ) | ||
0 | 1 | 3 |
1a | 6 | 18 |
1b | 4 | 12 |
2 | 19 | 58 |
3 | 3 | 9 |